FDA
approval
· 2019-11-29
FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
Summary
The FDA approved Sun Pharmaceutical's supplemental application to market a generic dexmethylphenidate hydrochloride product for attention-deficit/hyperactivity …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DEXMETHYLPHENIDATE HYDROCHLORIDE (DEXMETHYLPHENIDATE HYDROCHLORIDE)